Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
MicroRNA-223 is a key factor in osteoclast differentiation
T. Sugatani,
K. A. Hruska
Division of Nephrology, Hypertension & Apheresis
Institute of Clinical and Translational Sciences (ICTS)
Research output
:
Contribution to journal
›
Article
›
peer-review
170
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'MicroRNA-223 is a key factor in osteoclast differentiation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Osteoclast Differentiation
100%
MicroRNA-223
100%
Overexpression
37%
MicroRNA
37%
Knockdown
25%
Small Interfering RNA (siRNA)
25%
Control Cell
25%
RAW264.7 Cells
25%
Multinucleated Cells
25%
MiR-223
25%
Tartrate-resistant Acid Phosphatase
25%
Cell-to-cell
12%
Therapeutic Target
12%
Gene Expression
12%
Vertebrates
12%
Retroviral Vector
12%
Cell Formation
12%
Invertebrates
12%
Apoptotic Cells
12%
Messenger RNA (mRNA)
12%
Osteoclast Activity
12%
Bone Metabolism
12%
Osteoclast Precursor Cells
12%
Translational Inhibition
12%
Control Genes
12%
Precursor microRNA
12%
Bone Metabolic Disorder
12%
RNA Degradation
12%
Immunology and Microbiology
Precursor
100%
Osteoclastogenesis
100%
Gene Expression
25%
Cell Line
25%
Bone Remodeling
25%
Retrovirus Vector
25%
Osteoclast
25%
Osteoclast Activity
25%
RNA Degradation
25%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Osteoclastogenesis
100%
Precursor
36%
Small Interfering RNA
18%
Tartrate-Resistant Acid Phosphatase
18%
Retrovirus Vector
9%
Bone Remodeling
9%
RNA
9%
Osteoclast
9%
Gene Expression Control
9%
Osteoclast Activity
9%
RNA Degradation
9%
Messenger RNA
9%